{"nct_id":"NCT01596062","title":"Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)","status":"COMPLETED","status_verified_date":"2014-06","start_date":"2012-03","start_date_type":null,"primary_completion_date":"2013-03","primary_completion_date_type":"ACTUAL","completion_date":"2013-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}